**Author details**

Yoshinori Kawabata Division of Diagnostic Pathology, Saitama Prefectural Cardiovascular and Respiratory Center, Kumagaya, Japan

\*Address all correspondence to: kawabata.yoshinori@pref.saitama.lg.jp

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

*Asbestos Exposure Results in Asbestosis and Usual Interstitial Pneumonia Similar to Other… DOI: http://dx.doi.org/10.5772/intechopen.89247*

### **References**

[1] Craighead JE, Abraham JL, Churg A, et al. The pathology of asbestos associated diseases of the lungs and pleural cavities: Diagnostic criteria and proposed grading schema (Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health). Archives of Pathology & Laboratory Medicine. 1982;**106**:544-596

[2] Roggli VL, Gibbs AR, Attanoos R, et al. Pathology of asbestosis- An update of the diagnostic criteria: Report of the asbestosis committee of the college of American pathologists and pulmonary pathology society. Archives of Pathology & Laboratory Medicine. 2010;**134**:462- 480. DOI: 10.5858/arpa.2015-0503-SA

[3] Henderson DW, Rantanen J, Barnhart S, et al. Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. A consensus report of an international expert group. Scandinavian Journal of Work, Environment & Health. 1997;**28**:311-316

[4] Gaensler EA, Jederlinic PJ, Churg A. Idiopathic pulmonary fibrosis in asbestosexposed workers. The American Review of Respiratory Disease. 1991;**144**:689-696

[5] Roggli VL, Pratt PC, Brody AR. Asbestos content of lung tissue in asbestos associated diseases: A study of 110 cases. British Journal of Industrial Medicine. 1986;**43**:18-28

[6] Kobayashi H, Watanabe H, Zhang WM, Ohnishi Y. A quantitative and histological study on pulmonary effects of asbestos exposure in general autopsied lungs. Acta Pathologica Japonica. 1986;**36**:1781-1791

[7] Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H. Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: Recommendations.

Scandinavian Journal of Work, Environment & Health. 2015;**41**:5-15. DOI: 10.5271/sjweh.3462

[8] Roggli VL, Vollmer RT. Twentyfive years of fiber analysis: What have we learned? Human Pathology. 2008;**39**:307-315. DOI: 10.1016/j. humpath.2007.07.005

[9] Kawabata Y, Kasai T, Kobashi Y, et al. Grade 4 asbestosis does not extend directly from the respiratory bronchiole to the peripheral lung. Histopathology. 2018;**73**:29-37. DOI: 10.1111/his.13493

[10] Fischer M, Gunther S, Muller KM. Fibre-years, pulmonary asbestos burden and asbestosis. International Journal of Hygiene and Environmental Health. 2002;**205**:245-248

[11] Yamamoto S. Histopathological features of pulmonary asbestosis with particular emphasis on the comparison with those of usual interstitial pneumonia. Osaka City Medical Journal. 1997;**43**:225-242

[12] Warnock ML, Wolery G. Asbestos bodies or fibres and the diagnosis of asbestosis. Environmental Research. 1987;**44**:29-44

[13] Lynch DA, Sverzellati N, Travis WD, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: A Fleischner Society White Paper. The Lancet Respiratory Medicine. 2018;**6**:138-153. DOI: 10.1016/S2213-2600(17)30433-2

[14] Raghu G, Remy-Jardi M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis an official ATS/ ERS/JRS/ALAT clinical practice guideline. American Journal of Respiratory and Critical Care Medicine. 2018;**198**:e44-e68. DOI: 10.1164/ rccm.201807-1255ST

[15] McDonald S. Histology of pulmonary asbestosis. British Medical Journal. 1927;**2**:1025-1026

[16] Sporn TA, Roggli VL. Asbestosis. In: Roggli VL, Oury TD, Sporn TA, editors. Pathology of Asbestos-Associated Diseases. 2nd ed. New York: Springer; 2004. pp. 71-103

[17] Sébastien P, Bégin R, Masse S. Mass, number and size of lung fibres in the pathogenesis of asbestosis in sheep. Journal of Experimental Pathology (Oxford, England). 1990;**71**:1-10

[18] Roggli VL, Pratt PC, Brody AR. Analysis of tissue mineral fiber content. In: Roggli VL, Greenberg SD, Pratt PC, editors. Pathology of Asbestos-Associated Diseases. Boston, MA: Little, Brown & Co Inc.; 1992. pp. 299-345

[19] Hiroshima K. Report to the Ministry of the Environment of Japan 2012. Pathological and Radiographic Evaluation of Asbestos Exposure. Tokyo Women's Medical University; 2012

[20] Roggli VL, Pratt PC. Numbers of asbestos bodies on iron-stained tissue sections in relation to asbestos body counts in lung tissue digests. Human Pathology. 1983;**14**:355-361

[21] Kishimoto T, Kato K, Arakawa H, Ashizawa K, Inai K, Takeshima Y. Clinical, radiological, and pathological investigation of asbestosis. International Journal of Environmental Research and Public Health. 2011;**8**:899-912. DOI: 10.3390/ijerph8030899

[22] Arakawa H, Kishimoto T, Ashizawa K, et al. Asbestosis and other pulmonary fibrosis in asbestosexposed workers: High-resolution CT features with pathological correlations. European Radiology. 2016;**26**:1485-1492. DOI: 10.1007/s00330-015-3973-z

[23] Churg A. Nonneoplastic disease caused by asbestos. In: Churg A,

Green FHY, editors. Pathology of Occupational Lung Disease. 2nd ed. Baltimore, MD: Williams & Wilkins; 1998. pp. 277-338

[24] Attanoos RL, Alchami FS, Pooley FD, Gibbs AR. Usual interstitial pneumonia in asbestos-exposed cohorts - concurrent idiopathic pulmonary fibrosis or atypical asbestosis? Histopathology. 2016;**69**: 492-498. DOI: 10.1111/his.12951

[25] Churg A. Deposition and clearance of chrysotile asbestos. The Annals of Occupational Hygiene. 1994;**38**:625-633, 424-425

[26] Churg A, Wright JL, Gilks B, DePaoli L. Rapid short-term clearance of chrysotile compared with amosite asbestos in the guinea pig. The American Review of Respiratory Disease. 1989;**139**:885-890

[27] Miller A, Langer AM, Teirstein AS, Selikoff IJ. "Nonspecific" interstitial pulmonary fibrosis. Association with asbestos fibers detected by electron microscopy. The New England Journal of Medicine. 1975;**292**:91-93

[28] Monsó E, Tura JM, Pujadas J, Morell F, Ruiz J, Morera J. Lung dust content in idiopathic pulmonary fibrosis: A study with scanning electron microscopy and energy dispersive x ray analysis. British Journal of Industrial Medicine. 1991;**48**:327-331

[29] Holden J, Churg A. Asbestos bodies and the diagnosis of asbestosis in chrysotile workers. Environmental Research. 1986;**39**:232-236

[30] Dupres JS, Mustard JF, Uffen RJ. Report of the Royal Commission on Matters of Health and Safety Arising From the Use of Asbestos in Ontario. Queen's Printer for Ontario: Toronto, Canada; 1984

[31] De Vuyst P, Gevenois PA. Asbestosis. In: Hendrick DJ, Burge PS, Beckett WS,

*Asbestos Exposure Results in Asbestosis and Usual Interstitial Pneumonia Similar to Other… DOI: http://dx.doi.org/10.5772/intechopen.89247*

Churg A, editors. Occupational Disorders of the Lung: Recognition, Management, and Prevention. London: Saunders; 2002. pp. 143-162

[32] Browne K. A threshold for asbestosrelated lung cancer. British Journal of Industrial Medicine. 1986;**43**:556-558

[33] Green FH, Harley R, Vallyathan V, et al. Exposure and mineralogical correlates of pulmonary fibrosis in chrysotile asbestos workers. Occupational and Environmental Medicine. 1997;**54**:549-559

[34] Sluis-Cremer GK. Asbestos disease at low exposure after long residence time in amphibole miners. Toxicology and Industrial Health. 1991;**7**:89-95

[35] Sluis-Cremer GK, Hnizdo E, du Toit RS. Evidence for an amphibole asbestos threshold exposure for asbestosis assessed by autopsy in South African asbestos miners. The Annals of Occupational Hygiene. 1990;**34**:443-451

[36] Johansson LG, Albin MP, Jakobsson KM, Welinder HE, Ranstam PJ, Attewell RG. Ferruginous bodies and pulmonary fibrosis in dead low to moderately exposed asbestos cement workers: Histological examination. British Journal of Industrial Medicine. 1987;**44**:550-558

[37] Berry G, Gilson JC, Holmes S, Lewinsohn H, Roach S. Asbestosis: A study of dose response relationships in an asbestos textile factory. British Journal of Industrial Medicine. 1979;**36**:98-112

[38] Finkelstein MM. Asbestosis in long-term employees of an Ontario asbestos-cement factory. The American Review of Respiratory Disease. 1982;**125**:496-501

[39] Lockey JE, Brooks SM, Jarabek AM, et al. Pulmonary changes after exposure to vermiculite contaminated with

fibrous tremolite. The American Review of Respiratory Disease. 1984;**129**:952-958

[40] Ehrlich R, Lilis R, Chan E, Nicholson WJ, Selikoff IJ. Long term radiological effects of short term exposure to amosite asbestos among factory workers. British Journal of Industrial Medicine. 1992;**49**:268-275

[41] Jakobsson K, Strömberg U, Albin M, Welinder H, Hagmar L. Radiological changes in asbestos cement workers. Occupational and Environmental Medicine. 1995;**52**:20-27

[42] Stayner LT, Smith R, Bailer J, et al. Exposure-response analysis of respiratory disease risk associated with occupational exposure to chrysotile asbestos. Occupational and Environmental Medicine. 1997;**54**:646-652

[43] Paris C, Benichou J, Raffaelli C, et al. Factors associated with early-stage pulmonary fibrosis as determined by high-resolution computed tomography among persons occupationally exposed to asbestos. Scandinavian Journal of Work, Environment & Health. 2004;**30**:206-214

[44] Paris C, Martin A, Letourneux M, Wild P. Modelling prevalence and incidence of fibrosis and pleural plaques in asbestos-exposed populations for screening and follow-up: A cross-sectional study. Environmental Health. 2008;**7**:30. DOI: 10.1186/1476-069X-7-30

[45] Deng Q, Wang X, Wang M, Lan Y. Exposure-response relationship between chrysotile exposure and mortality from lung cancer and asbestosis. Occupational and Environmental Medicine. 2012;**69**: 81-86. DOI: 10.1136/oem.2011.064899

[46] Merewether ERA, Price GW. Report on Effects of Asbestos Dust on the Lungs and Suppression in the Asbestos

Industry. London: Her Majesty's Stationery Office; 1930. pp. 5-31

[47] Goff AM, Gaensler EA. Asbestosis following brief exposure in cigarette filter manufacture. Respiration. 1972;**29**:83-93

[48] Becklake MR, Liddell FD, Manfreda J, McDonald JC. Radiological changes after withdrawal from asbestos exposure. British Journal of Industrial Medicine. 1979;**36**:23-28

[49] Moy EV, Hu H, Christiani DC. A retired shipyard worker with rapidly progressive pulmonary interstitial fibrosis. Environmental Health Perspectives. 1999;**107**:321-327

[50] Kilburn KH, Lilis R, Anderson HA, et al. Asbestos diseases in family contacts of shipyard workers. American Journal of Public Health. 1985;**75**:615-617

[51] Magnani C, Mollo F, Paoletti L, et al. Asbestos lung burden and asbestosis after occupational and environmental exposure in an asbestos cement manufacturing area: A necropsy study. Occupational and Environmental Medicine. 1998;**55**:840-846

[52] Hilbert TJ, Franzblau A, Dunning KK, Borton EK, Rohs AM, Lockey JE. Asbestos-related radiographic findings among household contacts of workers exposed to Libby vermiculite: Impact of workers' personal hygiene practices. Journal of Occupational and Environmental Medicine. 2013;**55**:1300-1304. DOI: 10.1097/ JOM.0b013e31829fcf1a

[53] Lee EK, Kim JS, Kim Y, Park JS. CT findings in people who were environmentally exposed to asbestos in Korea. Journal of Korean Medical Science. 2015;**30**:1896-1901. DOI: 10.3346/jkms.2015.30.12.1896

[54] Kim Y, Myong JP, Lee JK, Kim JS, Kim YK, Jung SH. CT characteristics of pleural plaques related to occupational or environmental asbestos exposure from South Korean asbestos mines. Korean Journal of Radiology. 2015;**16**:1142-1152. DOI: 10.3348/ kjr.2015.16.5.1142

[55] Kang D, Kim YY, Shin M, et al. Relationships of lower lung fibrosis, pleural disease, and lung mass with occupational, household, neighborhood, and slate roof-dense area residential asbestos exposure. International Journal of Environmental Research and Public Health. 2018;**15**:E1638. DOI: 10.3390/ ijerph15081638

[56] Miserocchi G, Sancini G, Mantegazza F, Chiappino G. Translocation pathways for inhaled asbestos fibers. Environmental Health. 2008;**7**:4. DOI: 10.1186/1476-069X-7-4

[57] Helmig S, Aliahmadi N, Schneider J. Tumour necrosis factor-alpha gene polymorphisms in asbestos-induced diseases. Biomarkers. 2010;**15**:400-409. DOI: 10.3109/1354750X.2010.481365

[58] Helmig S, Belwe A, Schneider J. Association of transforming growth factor beta1 gene polymorphisms and asbestos-induced fibrosis and tumors. Journal of Investigative Medicine. 2009;**57**:655-661. DOI: 10.2310/ JIM.0b013e3181a4f32a

[59] Franko A, Dodic-Fikfak M, Arnerić N, Dolzan V. Glutathione S-transferases GSTM1 and GSTT1 polymorphisms and asbestosis. Journal of Occupational and Environmental Medicine. 2007;**49**:667-671

[60] Franko A, Dolžan V, Arnerić N, Dodič-Fikfak M. The influence of genegene and gene-environment interactions on the risk of asbestosis. BioMed Research International. 2013;**2013**:405743. DOI: 10.1155/2013/405743

[61] Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and

*Asbestos Exposure Results in Asbestosis and Usual Interstitial Pneumonia Similar to Other… DOI: http://dx.doi.org/10.5772/intechopen.89247*

prevalence of idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine. 2006;**174**:810-816

[62] Kawabata Y, Shimizu Y, Hoshi A, et al. Asbestos exposure increases the incidence of usual interstitial pneumonia. Histopathology. 2016;**68**:339-346. DOI: 10.1111/his.12751

[63] Barber CM, Wiggans RE, Young C, Fishwick D. UK asbestos imports and mortality due to idiopathic pulmonary fibrosis. Occupational Medicine. 2016;**66**:106-111. DOI: 10.1093/occmed/ kqv142

[64] Barber CM, Wiggans RE, Fishwick D. Estimating lifetime asbestos exposure in patients with idiopathic pulmonary fibrosis. The Annals of Occupational Hygiene. 2016;**60**: 649-650. DOI: 10.1093/annhyg/mew017

[65] Antao VC, Pinheiro GA, Wassell JT. Asbestosis mortality in the USA: Facts and predictions. Occupational and Environmental Medicine. 2009;**66**: 335-338. DOI: 10.1136/oem.2008.039172

[66] Kawabata Y, Watanabe T, Yamamura J, et al. A case of asbestosis without typical asbestos bodies. Nihon Kyōbu Shikkan Gakkai zasshi. 1985;**23**:1177-1183

[67] Iwai K, Mori T, Yamada N, Yamaguchi M, Hosoda Y. Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. American Journal of Respiratory and Critical Care Medicine. 1994;**150**:670-675

[68] Baumgartner KB, Samet JM, Coultas DB, et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: A multicenter casecontrol study. Collaborating Centers. American Journal of Epidemiology. 2000;**152**:307-315

[69] Hubbard R, Cooper M, Antoniak M, et al. Risk of cryptogenic fibrosing

alveolitis in metal workers. Lancet. 2000;**355**:466-467

[70] Pinheiro GA, Antao VC, Wood JM, Wassell JT. Occupational risks for idiopathic pulmonary fibrosis mortality in the United States. International Journal of Occupational and Environmental Health. 2008;**14**:117-123. DOI: 10.1179/oeh.2008.14.2.117

[71] Ley B, Collard HR. Epidemiology of idiopathic pulmonary fibrosis. Clinical Epidemiology. 2013;**5**:483-492. DOI: 10.2147/CLEP.S54815

[72] Ekström M, Gustafson T, Boman K, et al. Effects of smoking, gender and occupational exposure on the risk of severe pulmonary fibrosis: A population-based casecontrol study. British Medical Journal Open. 2014;**4**:e004018. DOI: 10.1136/ bmjopen-2013-004018

[73] Gulati M, Redlich CA. Asbestosis and environmental causes of usual interstitial pneumonia. Current Opinion in Pulmonary Medicine. 2015;**21**:193-200. DOI: 10.1097/ MCP.0000000000000144

[74] Armanios MY, Chen JJ, Cogan JD, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. The New England Journal of Medicine. 2007;**356**:1317-1326

[75] Alder JK, Chen JJ, Lancaster L, et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proceedings of the National Academy of Sciences of the United States of America. 2008;**105**:13051-13056. DOI: 10.1073/pnas.0804280105

[76] Kropski JA, Pritchett JM, Zoz DF, et al. Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease. American Journal of Respiratory and Critical Care Medicine. 2015;**191**:417-426. DOI: 10.1164/ rccm.201406-1162OC

[77] Seibold MA, Wise AL, Speer MC, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. The New England Journal of Medicine. 2011;**364**:1503-1512

[78] Newton CA, Oldham JM, Ley B, et al. Telomere length and genetic variant associations with interstitial lung disease progression and survival. The European Respiratory Journal. 2019;**53**:1801641. DOI: 10.1183/13993003.01641-2018

[79] Arakawa H, Johkoh T, Honma K, et al. Chronic interstitial pneumonia in silicosis and mix-dust pneumoconiosis: Its prevalence and comparison of CT findings with idiopathic pulmonary fibrosis. Chest. 2007;**131**:1870-1876

[80] McConnochie K, Green FHY, Vallyathan V, et al. Interstitial fibrosis in coal workers: Experience in Wales and West Virginia. In: Dodgson J, McCallum RI, Bailey MR, et al., editors. British Occupational Hygiene Society 6th International Symposium. Cambridge, UK: Pergamon Press; 1988. pp. 553-560

[81] Honma K, Chiyotani K. Diffuse interstitial fibrosis in nonasbestos pneumoconiosis—A pathological study. Respiration. 1993;**60**:120-126

[82] Katabami M, Dosaka-Akita H, Honma K, et al. Pneumoconiosis-related lung cancers: Preferential occurrence from diffuse interstitial fibrosis-type pneumoconiosis. American Journal of Respiratory and Critical Care Medicine. 2000;**162**:295-300

[83] Arakawa H, Fujimoto K, Honma K, et al. Progression from near-normal to end-stage lungs in chronic interstitial pneumonia related to silica exposure: Long-term CT observations. AJR. American Journal of Roentgenology. 2008;**191**:1040-1045. DOI: 10.2214/AJR.07.3871

[84] Tanaka J, Moriyama H, Terada M, et al. An observational study of giant cell interstitial pneumonia and lung fibrosis in hard metal lung disease. BMJ Open. 2014;**4**:e004407. DOI: 10.1136/ bmjopen-2013-004407

[85] Akashi T, Takemura T, Ando N, et al. Histopathologic analysis of sixteen autopsy cases of chronic hypersensitivity pneumonitis and comparison with idiopathic pulmonary fibrosis/usual interstitial pneumonia. American Journal of Clinical Pathology. 2009;**131**:405-415. DOI: 10.1309/AJCPNWX4SLZRP9SW

[86] Takemura T, Akashi T, Kamiya H, et al. Pathological differentiation of chronic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis/ usual interstitial pneumonia. Histopathology. 2012;**61**:1026-1035. DOI: 10.1111/j.1365-2559.2012.04322.x

[87] Churg A, Bilawich A, Wright JL. Pathology of chronic hypersensitivity pneumonitis what is it? What are the diagnostic criteria? Why do we care? Archives of Pathology & Laboratory Medicine. 2018;**142**:109-119. DOI: doi. org/10.5858/arpa.2017-0173-RA

[88] Ley B, Torgerson DG, Oldham JM, et al. Rare protein-altering telomererelated gene variants in patients with chronic hypersensitivity pneumonitis. American Journal of Respiratory and Critical Care Medicine. 3 July 2019. DOI: 10.1164/rccm.201902-0360OC

[89] Solomon JJ, Brown KK. Rheumatoid arthritis-associated interstitial lung disease. Open access Rheumatology: Research and Reviews. 2012;**4**:21-31

[90] Yunt ZX, Chung JH, Hobbs S, et al. High resolution computed tomography pattern of usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease: Relationship to survival. Respiratory Medicine. 2017;**126**:100-104. DOI: 10.1016/j. rmed.2017.03.027

*Asbestos Exposure Results in Asbestosis and Usual Interstitial Pneumonia Similar to Other… DOI: http://dx.doi.org/10.5772/intechopen.89247*

[91] Spagnolo P, Lee JS, Sverzellati N, Rossi G, Cottin V. The lung in rheumatoid arthritis: Focus on interstitial lung disease. Arthritis & Rhematology. 2018;**70**:1544-1554. DOI: 10.1002/art.40574

[92] Singh N, Varghese J, England BR, et al. Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: A systematic literature review and meta-analysis. Seminars in Arthritis and Rheumatism. 15 May 2019. pii: S0049-0172(18)30639-5. DOI: 10.1016/j. semarthrit.2019.04.005

[93] Song JW, Do KH, Kim MY, Jang SJ, Colby TV, Kim DS. Pathologic and radiologic differences between idiopathic and collagen vascular diseaserelated usual interstitial pneumonia. Chest. 2009;**136**:23-30. DOI: 10.1378/ chest.08-2572

[94] Juge PA, Lee JS, Ebstein E, et al. *MUC5B* promoter variant and rheumatoid arthritis with interstitial lung disease. The New England Journal of Medicine. 2018;**379**:2209-2219. DOI: 10.1056/NEJMoa1801562

### **Chapter 4**
